Posted by Michael Wonder on 22 Apr 2024
EMA publishes agenda for 22-25 April 2024 CHMP meeting
22 April 2024 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue opinions for the following technologies:
- Efanesoctocog alfa
- Eribulin mesylate
- Aprocitentan
- Vibegron
- Tocilizumab
- Capivasertib
- Ustekinumab
